Marcin P Mycko on Muck Rack

Marcin P Mycko

As seen in: Nature, MDPI, SAGE Publishing
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Marcin P

Contact Marcin P, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Safety and biodistribution of intrathecal administration of mesenchymal stem cells (MSCs) and neurotrophin-releasing nanoparticles in a porcine CSF-guided delivery model for amyotrophic lateral sclerosis (ALS) drug discovery | Scientific Reports

|
By Anna Sarnowska, Piotr Holak, Edyta Paczkowska, Marcin P Mycko, Emilia Sinderewicz, Joanna Staszkiewicz-Chodor, Dorota Mystkowska, Igor Drozd, Magdalena Chodkowska-Michalowska, Monika Rytel, Boguslaw Machalinski, Katarzyna Jezierska-Wozniak
| Nature
Abstract Amyotrophic lateral sclerosis (ALS) is a multifactorial neurodegenerative disorder that complicates the identification of effective therapeutic targets. The potential of stem cells and neurotrophins as promising candidates has become increasingly evident, owing to their neuroprotective and anti-inflammatory properties.
Open in Who Shared Issue with article?

Linking Mechanisms of Vitamin D Signaling with Multiple Sclerosis

|
By Carsten Carlberg, Marcin P Mycko
| MDPI
1. Introduction The central nervous system (CNS) autoimmune disease MS is the leading cause of disability in younger and middle-aged adults that is not caused by a trauma [1]. The clinically most common form of the disease is RRMS (relapsing remitting MS), i.e., an alternation between symptomatic attacks (relapses) and periods of recovery (remissions), which is found in up to 90% of patients in the age range of 20–40 years [2].
Open in Who Shared Issue with article?

Exosomal profiling should be used to monitor disease activity in MS patients: Yes

|
By Marcin P Mycko
| SAGE Publishing
Cite article If you have citation software installed, you can download article citation data to the citation manager of your choice Select your citation manager software: Share options Share this article Share with email EMAIL ARTICLE LINK Share on social media Share access to this article Sharing links are not relevant where the article is open access and not available if you do not have a subscription. For more information view the Sage Journals article sharing page.
Open in Who Shared View Duplicates (3) Issue with article?
See all 4 articles

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Get in touch with Marcin P

Contact Marcin P, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified